TherapeuticsMD, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
TherapeuticsMD, Inc. (TXMD) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$653.00 thousand for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-04-01.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-04-01
- TherapeuticsMD, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$653.00K.
- TherapeuticsMD, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$2.34M.
- TherapeuticsMD, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $1.07M.
- TherapeuticsMD, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$79.31M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$653.00K 10-K/A · filed 2026-04-01 | |
| 2024-12-31 | -$2.34M 10-K/A · filed 2026-04-01 | |
| 2022-12-31 | $1.07M 10-K · filed 2023-04-07 | |
| 2021-12-31 | -$79.31M 10-K · filed 2023-04-07 | -$172.41M 10-K · filed 2022-03-23 |
| 2020-12-31 | -$183.52M 10-K · filed 2022-03-23 | -$183.52M 10-K · filed 2021-03-04 |
| 2019-12-31 | -$176.15M 10-K · filed 2022-03-23 | -$176.14M 10-K · filed 2020-02-24 |
| 2018-12-31 | -$132.62M 10-K · filed 2021-03-04 | |
| 2017-12-31 | -$76.93M 10-K · filed 2020-02-24 | |
| 2016-12-31 | -$89.88M 10-K · filed 2019-02-27 | |
| 2015-12-31 | -$85.08M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |